Former New Zealand cricket captain, Martin Crowe has been diagnosed with lymphoma, cancer of lymphocytes.
Former New Zealand cricket captain, Martin Crowe, has been diagnosed with lymphoma. The family is in shock and trying to deal with the news, reports, IBN Live. Crowe’s manager and close family friend, Louise Henderson issued the statement.
Martin Crowe is second-highest run scorer in Test cricket in New Zealand . His score stands a 5444 runs in 77 cricket test matches. He was voted the Player of the Series in the 1992 World Cup. Crowe has since retired from cricket and is active in commentating and coaching the game.
What is Lymphoma?
Lymphoma is a cancer of the lymphocytes of the immune system which presents itself as a solid tumor of lymphoid cells. Lymphoma can be treated with chemotherapy, radiotherapy, and bone marrow transplantation. The tumor cells often make their appearance in lymph nodes and present themselves as enlargement of the node.
Lymphoma is part of a broad group of diseases called hematological neoplasms. It is the most common form of ‘blood cancer’ in developed countries. According to the NIH, lymphomas account for 5% of all cases of cancer in the US.
Symptoms of lymphoma: Some of the common symptoms of lymphoma include lymphadenopathy, fever of unknown origin, night sweats, pruritus, weight loss, anorexia, dyspnea and fatigue.
Treatment for lymphoma: Watchful waiting as the initial course of treatment monitors low risk/grade lymphoma. Once symptoms develop, chemotherapy or radiotherapy is advised. High grade lymphoma is treated with aggressive chemotherapy and CHOP regimen. Hodgkin’s lymphoma is localized and hence radiotherapy is the initial mode of treatment. If the disease advances, chemotherapy is also combined with radiotherapy.
There are many ongoing clinical trials for lymphoma and if you or your loved one would like to participate please visit, TrialX.
Give below is a list of ongoing clinical trials for lymphoma,
- Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
Related posts:
- Recurrent Mantle Cell Lymphoma Clinical Trials, Research Investigators and Treatments
- Peripheral T-Cell Lymphoma Clinical Trials
- Current Clinical Trials, New Treatments for Recurrent Adult Diffuse Large Cell Lymphoma
- Non-Hodgkins Lymphoma Clinical Trials and Treatments under Research
- Lymphoma Prognosis (Life Expectancy)